Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
4
57%
Ph phase_1
1
14%
Ph phase_2
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
N/A4 (57.1%)

Trials by Status

terminated114%
unknown114%
completed571%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25

NCT04641494
completednot_applicable

CLA and Vitamin D on Protein Turnover

NCT03115775
completedphase_2

Effects of CLA Supplements on Body Weight and Fat Oxidation

NCT00204932
terminatedphase_1

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

NCT00951158
unknownphase_2

Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children

NCT02063802
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04641494Not Applicable

The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25

Completed
NCT03115775Not Applicable

CLA and Vitamin D on Protein Turnover

Completed
NCT00204932Phase 2

Effects of CLA Supplements on Body Weight and Fat Oxidation

Completed
NCT00951158Phase 1

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

Terminated
NCT02063802Phase 2

Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children

Unknown
NCT00575991Not Applicable

Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children

Completed
NCT01026506Not Applicable

c9,t11-CLA in Children and Adolescents With Allergic Asthma

Completed

All 7 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7